UCSF-led study finds racial disparity in use of key treatment for stroke
Researchers led by UCSF scientists are reporting that a highly effective clot busting drug for stroke is significantly underutilized in all patient populations at U.S. academic medical centers, and is strikingly underutilized in African Americans.